Latest / Stock Movers / Hermes Drops, AstraZeneca Up, Brenntag Slumps
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios podcasts, radio news, The Stock Movers podcast,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:14Speaker 1: harnessing the power of Bloomberg Data.
- 0:17Speaker 2: Let's take a closer look at some of the stocks
- 0:20Speaker 2: on the move today in Europe. I'm Caroline Hepka and
- 0:22Speaker 2: I'm joined by Bloomberg's Markets Today sam Onsteed for more
- 0:26Speaker 2: on this story. Should we kick things off with the
- 0:29Speaker 2: French fashion giant Airmes not very good news for them
- 0:32Speaker 2: this morning. Is this on tariffs or something else?
- 0:37Speaker 3: Oh well, good morning, Caroline. It's actually a combination of
- 0:40Speaker 3: a couple of things. So tariff's in general the luxury
- 0:43Speaker 3: sector getting hit quite hard today. That's despite actually some
- 0:46Speaker 3: decent Chinese data coming out. You know, very often good
- 0:50Speaker 3: data up of China lifts the luxury sector. So is
- 0:52Speaker 3: that tariffs are overshadowing that today. So most of the
- 0:55Speaker 3: sector is in the red. Hermez is taking a little
- 0:58Speaker 3: bit of a harder hit. They got a downgraded from
- 1:00Speaker 3: Jeffries and it's part of a broader story that you know,
- 1:03Speaker 3: the luxury market has been in a bit of a downturn.
- 1:06Speaker 3: More tariffs, more concerns about the global economy are preventing
- 1:10Speaker 3: that any kind of recovery coming through for the luxury market.
- 1:14Speaker 3: And that's what Jeffries, who downgraded in MS today say
- 1:17Speaker 3: they struggle to see them getting back to the kind
- 1:19Speaker 3: of peak valuations that they've been at in the last
- 1:21Speaker 3: couple of years.
- 1:22Speaker 2: Yeah, absolutely so. And these are of course amongst Europe's
- 1:26Speaker 2: most valuable companies, the kind of luxury goods makers. Astra
- 1:30Speaker 2: Zeneca's new blockbuster drug positive signs in the latest trials.
- 1:35Speaker 2: How's the market taking that?
- 1:38Speaker 3: Yeah, So this is an experimental hypertension drug. I'm going
- 1:42Speaker 3: to attempt the name for you, Carolina, it's Backstrostat. They
- 1:46Speaker 3: bought this drug a couple of years ago when they
- 1:48Speaker 3: bought a company called Sincore Farmer, and they at the
- 1:51Speaker 3: time identified this drug as having potential sales of upwards
- 1:54Speaker 3: of five billion dollars a year, so would be a
- 1:57Speaker 3: major drug within their portfolio and a blockbuster. They got
- 2:00Speaker 3: very good results from it, so it met all of
- 2:03Speaker 3: the end points that were required in the trial that
- 2:05Speaker 3: they just had, so it puts it on the part
- 2:07Speaker 3: of potentially becoming a kind of blockbuster drug. So Astrosenica
- 2:11Speaker 3: shares up about two percent, and actually that's helping to
- 2:13Speaker 3: lift the UK's Futotzy one hundred into positive territory today.
- 2:17Speaker 3: So although most stocks across Europe are falling because of
- 2:19Speaker 3: the tariff news and most benchmarks are down, the Footy
- 2:22Speaker 3: one hundred is actually out performing and a big part
- 2:24Speaker 3: of that is astrosenicas shares.
- 2:25Speaker 2: Rising, Okayseneca. Then we also have the German chemicals firm
- 2:30Speaker 2: Brent Tag dropping they've given us their full year guidance, yeah.
- 2:37Speaker 3: And a cut to their full year guidance and less
- 2:39Speaker 3: actually saying it's not totally surprising that that had happened,
- 2:41Speaker 3: that their shares have dropped about four or five percent.
- 2:44Speaker 3: For the most part, you know, the chemicals companies are
- 2:47Speaker 3: right at the center of many many supply chains, and
- 2:50Speaker 3: so when you get any kind of concern about an
- 2:53Speaker 3: industrial slowdown, about any weaknesses on either side kind of
- 2:57Speaker 3: any kind of industrial market, and then particularly Inermany at
- 3:00Speaker 3: the moment, those companies get hit very hard. Brent tug
- 3:04Speaker 3: As I say, unless don't think it's enormously surprising because
- 3:08Speaker 3: of all the tariff news that's been coming through and
- 3:09Speaker 3: the concerns that's that's creating for the industrial market and
- 3:13Speaker 3: a slowdown in orders for brentug but still a profit.
- 3:17Speaker 3: A profit warning and you know, very early in the season,
- 3:20Speaker 3: so it doesn't read very well for the rest of
- 3:22Speaker 3: the reporting season for German German chemicals companies.
- 3:26Speaker 1: The Stock Movers podcast from Bloomberg Radio. Check back with
- 3:30Speaker 1: us throughout the day for the latest roundup of companies
- 3:33Speaker 1: making news on Wall Street and for the latest market
- 3:36Speaker 1: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 3:40Speaker 1: Bloomberg dot com, and on Applecarplay and Android Otto with
- 3:44Speaker 1: the Bloomberg Business app.